tiprankstipranks
Neurosense Therapeutics Secures $30 Million Equity Deal
Company Announcements

Neurosense Therapeutics Secures $30 Million Equity Deal

Neurosense Therapeutics Ltd. (NRSN) has released an update.

Pick the best stocks and maximize your portfolio:

Neurosense Therapeutics Ltd. has entered into a standby equity purchase agreement with YA II PN, LTD. to sell up to $30 million in ordinary shares, which are traded on the Nasdaq under the symbol ‘NRSN.’ This agreement allows the company to issue and sell shares at its discretion, providing financial flexibility to support its business operations.

For further insights into NRSN stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskNeuroSense Advances ALS Treatment with PrimeC, Boosts Financial Position
TheFlyNeuroSense reports first nine months EPS (48c) vs. (55c) last year
TipRanks Auto-Generated NewsdeskNeuroSense Therapeutics Regains Nasdaq Compliance
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App